WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 8401 Infant (under 12 months) mortality rate: 482
GDP / capita (US$): 1'7611 Child (under 5 years) mortality rate: 732

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 43'178  42'028  40'909  39'825  38'773  31'285  23'446  16'268 
Births 1'535  1'520  1'503  1'485  1'465  1'211  988  807 
Surviving infants 1'455  1'438  1'420  1'400  1'379  1'124  920  747 
Pop. less than 5 years 6'956  6'855  6'742  6'615  6'486  5'107  4'457  3'347 
Pop. less than 15 years 18'295  17'854  17'413  16'970  16'533  13'816  11'482  8'129 
Female 15-49 years 10'468  10'183  9'911  9'659  9'419  7'526  5'078  3'374 

Number of reported case

(Click for retrospective incidence data for Kenya)
Diphtheria 15  6'395 
Japanese encephalitis
Measles 2'395  95  1'218  1'282  21'002  77'072  28'473 
Mumps 30'468 
Pertussis 424  7'404  13'281 
Polio* 19  1'528  455 
Rubella 610  473  1'305  1'280 
Rubella (CRS)
Tetanus (neonatal) 30  1'278  1'612 
Tetanus (total) 30  1'278  1'692  831 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Kenya)
Vaccine year result method % card seen                                                
BCG 2007  96  DHS   70.4  84  92  99  75  95  75  54 
DTP1 2007  96  DHS   70.4  89  95  93  80  90  73 
DTP3 2007  86  DHS   70.4  83  88  83  75  85  63  42 
HepB_BD         
HepB3 2007  86  DHS   70.4  83  88  83  75  85 
Hib3 2007  86  DHS   70.4  83  88  83  75  85 
JapEnc         
MCV 2007  85  DHS   70.4  93  87  86  74  90  46  41 
MCV2         
PCV1          88  99* 
PCV3          82  85 
Pol3 2007  88  DHS   70.4  82  88  83  71  85  62  44 
Rota1         
Rota_last         
Rubella1         
TT2plus 2003  52  DHS   59.9  76  72  60  85  51  45 
PAB         
VAD1          22  33  18  68  80 
YFV 2007  DHS   70.4  66  56  36  90  11 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Kenya)
BCG 84  92  99  97  95  91  92 
DTP1 89  95  93  92  90  83  92 
DTP3 83  88  83  84  85  82  84 
HepB3 83  88  83  84  85 
Hib3 83  88  83  84  85 
MCV 93  87  86  88  90  78  78 
PAB 73  73  78  78  78  68  60 
PCV3 82  85 
Pol3 82  88  83  84  85  80  84 
Rota_last
YFV

Number of districts in the country 203  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
91 
   
/
|
|
\
Greater or equal to 90% 30
From 80 to 89% 23
From 50 to 79% 42
Less than 50% 5
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6,10,14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
TT 1st contact pregnancy; +1 months; 2nd, 3rd, 4th pregancies; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes
YF 9 months; No

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2017  2010-2015  2011 -2015    2005 - 2010  2005-2010  2005 to 2010 
Nº of districts with microplans that include activities to raise immunization coverage number     149  149  78  78  78 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 203  153  149  149  78  78  78 
Nº districts with DTP3 coverage >=80% number 108  104  88  62  34  45  50 
% of districts with DTP3 coverage >=80% From 0 to 100% 53  68  59  42  44  58  64 
Nº districts with measles (MCV1) coverage >=95% number 71  49  45  26  13     
% of districts with MCV1 coverage >=95% From 0 to 100% 35  32  30  17  17     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   57  48    100    80 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No No  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.